ArticleFrontiers in medicine2025
Brain functional connectivity analysis of fMRI-based Alzheimer's disease data.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Dissecting neuronal circuit function and dysfunction in Alzheimer's disease mouse models: from conventional calcium imaging analysis to machine learning-based approaches.Frontiers in aging neuroscience · 2026Review
- Integration of Neuroimaging and Molecular Biomarkers in the Diagnosis of Alzheimer's Disease and Frontotemporal Dementia: The Promise of fMRI.Current Alzheimer research · 2025Review
- Integration of Neuroimaging and Molecular Biomarkers in the Diagnosis of Alzheimer's Disease and Frontotemporal Dementia: The Promise of fMRI.Current Alzheimer research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of Alzheimer's disease (AD) poses a significant public health challenge. Distinguishing AD stages remains a complex process due to ambiguous variability within and across AD stages. Manual classification of such multifaceted and massive data of brain volumes is operationally inefficient and vulnerable to human errors. Here, we propose a precise and systematic framework for AD stages classification. The core of this framework discovers and analyzes functional connectivity among regions of interest (ROIs) of a human brain. Multivariate Pattern Analysis (MVPA) is applied to extract features that reveal complex functional connectivity patterns in the brain. These features are then used as inputs for an Extreme Learning Machine (ELM) model to classify AD stages. The model's performance is assessed through comprehensive evaluation metrics to ensure robustness and reliability. Applying this framework on datasets which contain meticulously validated fMRI scans such as the OASIS and AD Neuroimaging Initiative datasets, we validate the merit of this proposed work. The framework's results show improvement in the collective performance of two-class and multi-class classification. Feeding ELM with MVPA features yield decent outcomes given a generalizable and computationally-efficient model. This study underscores the effectiveness of the proposed approach in accurately distinguishing AD stages, offering potential improvements in AD and AD stages detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.